Market Tracker

12/09 5:16pm ET

Nektar Therapeutics (NASDAQ:NKTR)

13.28
Delayed Data
As of Dec 09
 +0.33 / +2.55%
Today’s Change
10.52
Today|||52-Week Range
19.98
-21.19%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.95
Today’s open13.06
Day’s range12.98 - 13.40
Volume1,984,026
Average volume (3 months)1,595,888
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-80.60%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book272.52

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...-0.27-1.44%
RDUSRadius Health Inc-3.13-6.65%
ONCESpark Therapeutics I...-3.79-6.80%
KITEKite Pharma Inc+0.82+1.82%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts